You are here: Welcome » Mood Disorders Association of Ontario

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
mood_disorders_association_of_ontario [2022/03/02 06:26]
liam 		mood_disorders_association_of_ontario [2022/03/02 17:22] (current)
liam [Mood Disorders Association of Ontario]
Line 3: Line 3:
 {{ ::mdao_logo.png?200|}} {{ ::mdao_logo.png?200|}}
  
-//This page is under construction.// +The **Mood Disorders Association of Ontario** (MDAO) is a Canadian counselling and support initiative based in the [[City of Toronto]], [[canada:Ontario]].
 ===== Affiliations ===== ===== Affiliations =====
  
 +==== Centre for Addiction and Mental Health ====
 +
 +Since 2019, the MDAO has collaborated with [[Centre for Addiction and Mental Health]] (CAMH) on twelve workshop webinars for older people across Ontario. These workshops are designed for older adults from immigrant, refugee, ethno-cultural, and racialized groups (IRER) and welcome Indigenous older adults.
 ==== Hong Fook Mental Health Foundation ==== ==== Hong Fook Mental Health Foundation ====
  
-MDAO is partnered with the [[Hong Fook Mental Health Foundation]].((//2020-21 Annual Report.// (2021). Mood Disorders Association of Ontario. https://mooddisorders.ca/sites/default/files/annualreports/annual_report_2021_final.pdf))+MDAO is partnered with the [[Hong Fook Mental Health Foundation]].((//2020-21 Annual Report.// (2021). Mood Disorders Association of Ontario. https://web.archive.org/web/20220302052622/https://mooddisorders.ca/sites/default/files/annualreports/annual_report_2021_final.pdf)) 
 + 
 +==== Sunnybrook Health Sciences Centre ====
  
 +The Department of Psychiatry at [[Sunnybrook Health Sciences Centre]] is described as one of MDAO's "most important strategic partners".
 ===== Funding ===== ===== Funding =====
  
 The MDAO receives funding from [[pharmaceutical_companies:AstraZeneca]], [[Barrick Gold Corporation]], [[CIBC]], [[City of Toronto]], [[pharmaceutical_companies:Eli Lilly]], [[[[pharmaceutical_companies:GlaxoSmithKline]], [[Loblaws]], [[Ontario Health]], [[Ontario Ministry of Health and Long-Term Care]], [[RBC (Royal Bank of Canada)]], and [[TD Bank Group]].((//Our Supporters.//  Mood Disorders Association of Ontario. Retrieved March 1, 2022, from https://archive.ph/ZWXhR)) The MDAO receives funding from [[pharmaceutical_companies:AstraZeneca]], [[Barrick Gold Corporation]], [[CIBC]], [[City of Toronto]], [[pharmaceutical_companies:Eli Lilly]], [[[[pharmaceutical_companies:GlaxoSmithKline]], [[Loblaws]], [[Ontario Health]], [[Ontario Ministry of Health and Long-Term Care]], [[RBC (Royal Bank of Canada)]], and [[TD Bank Group]].((//Our Supporters.//  Mood Disorders Association of Ontario. Retrieved March 1, 2022, from https://archive.ph/ZWXhR))
Back to top